Sadakatsu Ikeda, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Brachytherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Radiation Therapy Targeted Therapy
Dr. Sadakatsu Ikeda graduated from the Hokkaido University Faculty of Medicine and completed his residency program at the Mount Sinai Beth Israel. Then, he did a fellowship at the University of Michigan Hospitals and Health Centers. She is specialized in Medical Oncology and board certified in Internal Medicine, Hematology and Oncology. Dr. Ikeda has been in practice for more than 11 years and is affiliated with the UC San Diego Health System. During his career, he has also contributed to 6 clinical research publications.
Hokkaido University Faculty of Medicine
Medical School
Mount Sinai Beth Israel
Residency
University of Michigan Hospitals and Health Centers
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
CA State Medical License 2014 - 2018
Expression and function of microRNAs in heart disease.
Ikeda S Pu WT; Curr Drug Targets. 2010 Aug .
See more >>Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy.
Bisping E, Ikeda S, Sedej M, Wakula P, McMullen JR, Tarnavski O, Sedej S, Izumo S, Pu WT, Pieske B; J. Biol. Chem.. 2012-03-23.
See more >>Endostatin lowers blood pressure via nitric oxide and prevents hypertension associated with VEGF inhibition.
Sunshine SB, Dallabrida SM, Durand E, Ismail NS, Bazinet L, Birsner AE, Sohn R, Ikeda S, Pu WT, Kulke MH, Javaherian K, Zurakowski D, Folkman JM, Rupnick M; Proc. Natl. Acad. Sci. U.S.A.. 2012-07-10.
See more >>American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology